Log In
BCIQ
Print this Print this
 

bavituximab (3G4)

Also known as: formerly Tarvacin

  Manage Alerts
Collapse Summary General Information
Company Peregrine Pharmaceuticals Inc.
DescriptionChimeric mAb against phosphatidylserine
Molecular Target Phosphatidylserine
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/23/2015

Undisclosed

Undisclosed

Undisclosed

06/15/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today